GMAB NASDAQ
Genmab A/S
1W: +14.3%
1M: +26.3%
3M: +56.6%
YTD: +40.4%
1Y: +49.5%
3Y: +49.7%
5Y: -1.4%
$44.67
-0.01 (-0.03%)
Pre-Market: $44.97 (+0.30, +0.67%)
Weekly Expected Move ±8.1%
$37
$40
$44
$47
$51
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: $301.5M held by 241 funds, 181 bp over Treasuries → details ▾
If the stock fell to about $0.65 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.47B.
Distance to default 7.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Total debt $5.27B against a stock market value of $27.47B.
Distance to default 7.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$4B
Revenue
-77.7% YoY
$788M
Net Income
-89.4% YoY
$867M
Free Cash Flow
-80.1% YoY
92.7%
Gross Margin
35.2%
Op. Margin
26.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE4.0%
ROA2.9%
ROIC11.9%
Valuation
P/E35.0
P/B4.6
EV/EBITDA17.0
Leverage
Debt/Equity0.89
Current Ratio2.46
Interest Cov.4.4x
Quality Scores
Piotroski F4/9
Altman Z2.84
Beneish M-3.51